| |
 |
Brand Positioning: Instrumentation for Genomic Analysis
|
Report #07-369
Publication Date: October 2007
Page Count: 159
Individual Report (electronic copy with company-wide
license and one print copy): $4,000
plus Data Set: an additional $1,000
Full Package (all six individual reports): $12,000
|
BioInformatics LLC Publishes Study of Preferred Brands in Genomic Analysis; Findings Discussed in Webinars
ARLINGTON, VA -- October 26, 2007 -- BioInformatics, LLC, a leading market research and consulting firm to the life sciences industry, today released its latest research report: "Brand Positioning: Genomic Analysis Instrumentation." The report one in a series of six focused on brand positioning in various life science product categories.
"We found the genomic analysis market to be highly competitive, with companies competing on the bases of their ability to customize products and deliver specific performance features," said Dr. Tamara Zemlo, Director of Syndicated Research at BioInformatics. "As such, brand positioning is determined by more than traditional product features."
Key findings of the reports will be shared in a complimentary webinar. The webinar will be presented: Tuesday, October 30 at 11:00 am EDT; Wednesday, November 7 at 1:00 pm EST; and Wednesday, November 28 at 11:00 am EST. To register to attend one of the sessions, please email webinars@gene2drug.com.
Specific companies profiled in detail in this report include: Affymetrix (NASDAQ:AFFX); Agilent Technologies (NYSE:A); Applied Biosystems (NYSE:ABI); Beckman Coulter (NYSE:BEC); Bio-Rad Laboratories (AMEX:BIO); GE Healthcare (a division of General Electric, NYSE:GE); Illumina (NASDAQ:ILMN); Molecular Devices (a division of MDS, Inc., NYSE:MDZ); and Stratagene (a division of Agilent Technologies, NYSE:A).
The other five product categories analyzed in related reports are: cell biology kits and reagents; gene expression and analysis products; instrumentation for protein analysis; nucleic acid purification products; and protein separation products. These reports examine the leading brands using a variety of models across a ‘4D’ methodology - distinct, desirable, delivery and durable.
For a complimentary Executive Summary of this report, please visit http://www.gene2drug.com/reports
ABOUT BIOINFORMATICS, LLC
BioInformatics, LLC is the premier research and consulting firm serving the life science industry. By leveraging our global online panel of more than 30,000 biomedical researchers, we have supported more than 300 companies and provided insights that lead to better business decisions. Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.
For more information, please contact:
Amanda Donathen
BioInformatics, LLC
2111 Wilson Blvd., Suite 250
Arlington, VA 22201
703.778.3080 x14 (phone)
703.778.3081 (fax)
a.donathen@gene2drug.com
http://www.gene2drug.com/
|
|
